GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer

Sherif Abdel-Rahman, W. A. Anwar, W. E. Abdel-Aal, H. M. Mostafa, W. W. Au

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

The role of the polymorphic glutathione S-transferase genes GSTM1 and GSTT1 in the development and in the clinicopathological outcome of bladder cancer was investigated in 37 Egyptian bladder cancer patients and 34 matched controls. Of the 37 patients studied, 26 had transitional cell carcinoma (TCC) and 11 had squamous cell carcinoma (SCC). Fourteen out of twenty-six TCC and four out of eleven SCC patients were infected with schistosoma. We observed an increased relative risk for bladder cancer associated with the GSTM1 null genotype (OR = 2.99; 95% CL = 1.01-9,00; p = 0.02). The relative risk was more pronounced in squamous cell carcinoma (SCC) (OR = 5.70; 95% CL = 0.91-36.70; p = 0.03) than in transitional cell carcinoma (TCC) (OR = 2.39; 95% CL = 0.73-7.90; p = 0.08). Our results also indicate that the GSTT1 polymorphism is individually associated with increased risk for bladder cancer (OR = 4.93; 95% CL = 1.39-18.42; p = 0.004) with no preferential increase in risk with respect to the type of the carcinoma. Individuals with the null genotype for both GSTM1 and GSTT1 were at a significantly higher risk for developing bladder cancer than individuals with both genes present (OR = 9.92; 95% CL = 1.84-46.90; p = 0.001). These individuals were more susceptible to developing SCC than TCC (OR = 14.16; 95% CL = 1.35-131.35; p = 0.01; and OR: 8.5; 95% CL = 1.38-60.10; p = 0.007, respectively). In conclusion, our results indicate that the null genotypes for GSTM1 and GSTT1, either individually or in combination, are important host risk factors for bladder cancer. In addition, the null GSTM1 genotype may also affect the clinicopathological tumor outcome. Since the deleted genotypes for GSTM1 and GSTT1 are prevalent in the general population, the identification of these individuals may provide a useful public health approach for early detection and prevention of environmental cancers.

Original languageEnglish (US)
Pages (from-to)129-138
Number of pages10
JournalCancer Detection and Prevention
Volume22
Issue number2
StatePublished - 1998

Fingerprint

Urinary Bladder Neoplasms
Transitional Cell Carcinoma
Genotype
Squamous Cell Carcinoma
Genes
Schistosoma
Glutathione Transferase
Neoplasms
Public Health
Carcinoma
Population

Keywords

  • Bladder cancer
  • Genetic polymorphism
  • GSTM1
  • GSTT1
  • Multiplex
  • Polymerase chain reaction
  • Schistosomiasis

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Abdel-Rahman, S., Anwar, W. A., Abdel-Aal, W. E., Mostafa, H. M., & Au, W. W. (1998). GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer. Cancer Detection and Prevention, 22(2), 129-138.

GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer. / Abdel-Rahman, Sherif; Anwar, W. A.; Abdel-Aal, W. E.; Mostafa, H. M.; Au, W. W.

In: Cancer Detection and Prevention, Vol. 22, No. 2, 1998, p. 129-138.

Research output: Contribution to journalArticle

Abdel-Rahman, S, Anwar, WA, Abdel-Aal, WE, Mostafa, HM & Au, WW 1998, 'GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer', Cancer Detection and Prevention, vol. 22, no. 2, pp. 129-138.
Abdel-Rahman, Sherif ; Anwar, W. A. ; Abdel-Aal, W. E. ; Mostafa, H. M. ; Au, W. W. / GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer. In: Cancer Detection and Prevention. 1998 ; Vol. 22, No. 2. pp. 129-138.
@article{25941a3c7f4d47efa32c96fd3394d76e,
title = "GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer",
abstract = "The role of the polymorphic glutathione S-transferase genes GSTM1 and GSTT1 in the development and in the clinicopathological outcome of bladder cancer was investigated in 37 Egyptian bladder cancer patients and 34 matched controls. Of the 37 patients studied, 26 had transitional cell carcinoma (TCC) and 11 had squamous cell carcinoma (SCC). Fourteen out of twenty-six TCC and four out of eleven SCC patients were infected with schistosoma. We observed an increased relative risk for bladder cancer associated with the GSTM1 null genotype (OR = 2.99; 95{\%} CL = 1.01-9,00; p = 0.02). The relative risk was more pronounced in squamous cell carcinoma (SCC) (OR = 5.70; 95{\%} CL = 0.91-36.70; p = 0.03) than in transitional cell carcinoma (TCC) (OR = 2.39; 95{\%} CL = 0.73-7.90; p = 0.08). Our results also indicate that the GSTT1 polymorphism is individually associated with increased risk for bladder cancer (OR = 4.93; 95{\%} CL = 1.39-18.42; p = 0.004) with no preferential increase in risk with respect to the type of the carcinoma. Individuals with the null genotype for both GSTM1 and GSTT1 were at a significantly higher risk for developing bladder cancer than individuals with both genes present (OR = 9.92; 95{\%} CL = 1.84-46.90; p = 0.001). These individuals were more susceptible to developing SCC than TCC (OR = 14.16; 95{\%} CL = 1.35-131.35; p = 0.01; and OR: 8.5; 95{\%} CL = 1.38-60.10; p = 0.007, respectively). In conclusion, our results indicate that the null genotypes for GSTM1 and GSTT1, either individually or in combination, are important host risk factors for bladder cancer. In addition, the null GSTM1 genotype may also affect the clinicopathological tumor outcome. Since the deleted genotypes for GSTM1 and GSTT1 are prevalent in the general population, the identification of these individuals may provide a useful public health approach for early detection and prevention of environmental cancers.",
keywords = "Bladder cancer, Genetic polymorphism, GSTM1, GSTT1, Multiplex, Polymerase chain reaction, Schistosomiasis",
author = "Sherif Abdel-Rahman and Anwar, {W. A.} and Abdel-Aal, {W. E.} and Mostafa, {H. M.} and Au, {W. W.}",
year = "1998",
language = "English (US)",
volume = "22",
pages = "129--138",
journal = "Cancer Epidemiology",
issn = "1877-7821",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer

AU - Abdel-Rahman, Sherif

AU - Anwar, W. A.

AU - Abdel-Aal, W. E.

AU - Mostafa, H. M.

AU - Au, W. W.

PY - 1998

Y1 - 1998

N2 - The role of the polymorphic glutathione S-transferase genes GSTM1 and GSTT1 in the development and in the clinicopathological outcome of bladder cancer was investigated in 37 Egyptian bladder cancer patients and 34 matched controls. Of the 37 patients studied, 26 had transitional cell carcinoma (TCC) and 11 had squamous cell carcinoma (SCC). Fourteen out of twenty-six TCC and four out of eleven SCC patients were infected with schistosoma. We observed an increased relative risk for bladder cancer associated with the GSTM1 null genotype (OR = 2.99; 95% CL = 1.01-9,00; p = 0.02). The relative risk was more pronounced in squamous cell carcinoma (SCC) (OR = 5.70; 95% CL = 0.91-36.70; p = 0.03) than in transitional cell carcinoma (TCC) (OR = 2.39; 95% CL = 0.73-7.90; p = 0.08). Our results also indicate that the GSTT1 polymorphism is individually associated with increased risk for bladder cancer (OR = 4.93; 95% CL = 1.39-18.42; p = 0.004) with no preferential increase in risk with respect to the type of the carcinoma. Individuals with the null genotype for both GSTM1 and GSTT1 were at a significantly higher risk for developing bladder cancer than individuals with both genes present (OR = 9.92; 95% CL = 1.84-46.90; p = 0.001). These individuals were more susceptible to developing SCC than TCC (OR = 14.16; 95% CL = 1.35-131.35; p = 0.01; and OR: 8.5; 95% CL = 1.38-60.10; p = 0.007, respectively). In conclusion, our results indicate that the null genotypes for GSTM1 and GSTT1, either individually or in combination, are important host risk factors for bladder cancer. In addition, the null GSTM1 genotype may also affect the clinicopathological tumor outcome. Since the deleted genotypes for GSTM1 and GSTT1 are prevalent in the general population, the identification of these individuals may provide a useful public health approach for early detection and prevention of environmental cancers.

AB - The role of the polymorphic glutathione S-transferase genes GSTM1 and GSTT1 in the development and in the clinicopathological outcome of bladder cancer was investigated in 37 Egyptian bladder cancer patients and 34 matched controls. Of the 37 patients studied, 26 had transitional cell carcinoma (TCC) and 11 had squamous cell carcinoma (SCC). Fourteen out of twenty-six TCC and four out of eleven SCC patients were infected with schistosoma. We observed an increased relative risk for bladder cancer associated with the GSTM1 null genotype (OR = 2.99; 95% CL = 1.01-9,00; p = 0.02). The relative risk was more pronounced in squamous cell carcinoma (SCC) (OR = 5.70; 95% CL = 0.91-36.70; p = 0.03) than in transitional cell carcinoma (TCC) (OR = 2.39; 95% CL = 0.73-7.90; p = 0.08). Our results also indicate that the GSTT1 polymorphism is individually associated with increased risk for bladder cancer (OR = 4.93; 95% CL = 1.39-18.42; p = 0.004) with no preferential increase in risk with respect to the type of the carcinoma. Individuals with the null genotype for both GSTM1 and GSTT1 were at a significantly higher risk for developing bladder cancer than individuals with both genes present (OR = 9.92; 95% CL = 1.84-46.90; p = 0.001). These individuals were more susceptible to developing SCC than TCC (OR = 14.16; 95% CL = 1.35-131.35; p = 0.01; and OR: 8.5; 95% CL = 1.38-60.10; p = 0.007, respectively). In conclusion, our results indicate that the null genotypes for GSTM1 and GSTT1, either individually or in combination, are important host risk factors for bladder cancer. In addition, the null GSTM1 genotype may also affect the clinicopathological tumor outcome. Since the deleted genotypes for GSTM1 and GSTT1 are prevalent in the general population, the identification of these individuals may provide a useful public health approach for early detection and prevention of environmental cancers.

KW - Bladder cancer

KW - Genetic polymorphism

KW - GSTM1

KW - GSTT1

KW - Multiplex

KW - Polymerase chain reaction

KW - Schistosomiasis

UR - http://www.scopus.com/inward/record.url?scp=0031945060&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031945060&partnerID=8YFLogxK

M3 - Article

C2 - 9544433

AN - SCOPUS:0031945060

VL - 22

SP - 129

EP - 138

JO - Cancer Epidemiology

JF - Cancer Epidemiology

SN - 1877-7821

IS - 2

ER -